CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −4,339 | $5.42 | $24K | 182,625 |
| 2026-02-19 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award | +62,500 | 186,964 | ||
| 2026-02-19 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-18 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −6,225 | $5.10 | $32K | 124,464 |
| 2025-07-14 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −853 | $2.61 | $2K | 130,689 |
| 2025-02-27 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award · Stock Option (Right to Buy) | +272,575 | 272,575 | ||
| 2025-02-18 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −6,618 | $2.95 | $20K | 86,579 |
| 2025-02-13 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −1,425 | $2.99 | $4K | 93,197 |
| 2024-07-15 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −784 | $6.02 | $5K | 94,622 |
| 2024-02-27 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award | +44,963 | 131,542 | ||
| 2024-02-20 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −1,951 | $5.48 | $11K | 85,641 |
| 2024-02-16 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award | +39,000 | 87,592 | ||
| 2024-02-16 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-02-12 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −1,349 | $5.53 | $7K | 48,592 |
| 2023-07-11 | Overdorf Michael EVP & Chief Business Officer | Sale | −978 | $3.84 | $4K | 45,802 |
| 2023-02-16 | Overdorf Michael EVP & Chief Business Officer | Grant or award | +18,975 | 46,780 | ||
| 2023-02-16 | Overdorf Michael EVP & Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +77,050 | 77,050 | ||
| 2023-02-14 | Overdorf Michael EVP & Chief Business Officer | Sale | −144 | $6.30 | $907 | 27,805 |
| 2023-02-13 | Overdorf Michael EVP & Chief Business Officer | Sale | −1,501 | $6.30 | $9K | 27,949 |
| 2022-07-11 | Overdorf Michael EVP & Chief Business Officer | Grant or award | +9,375 | 21,875 |
Page 1 of 2 · 25 trades